Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Acta Ophthalmol Scand ; 78(4): 425-9, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10990045

ABSTRACT

PURPOSE: To analyse the characteristics of eyelid basal cell carcinomas excised using Mohs' micrographic technique. METHODS: Sixty-six eyelid basal cell carcinomas were excised using Mohs' micrographic technique. The tumours were classified into four subtypes; morpheiform, intermediate, nodular/micronodular and superficial. Data on previous treatment of the tumours were retrieved. RESULTS: Thirty-two tumours (48%) were primary, 8 tumours (12%) were incompletely excised using conventional excision surgery and 26 tumours (39%) were recurrent. Nineteen of the 26 (73%) recurrent tumours and 14 of the 32 (44%) primary tumours were nodular/micronodular. To achieve radical excision, superficial tumours needed an average of 2.0, nodular/micronodular 2.5, intermediate 2.0 and morpheiform tumours 2.9 excisions. CONCLUSIONS: Eyelid basal cell carcinomas with ill-defined borders or recurrent tumours are well suited for Mohs' micrographic surgery. The extensions of the tumours are difficult to determine even in some less aggressive subtypes such as superficial and nodular/micronodular basal cell carcinomas.


Subject(s)
Carcinoma, Basal Cell/surgery , Eyelid Neoplasms/surgery , Mohs Surgery/methods , Adult , Age Distribution , Aged , Aged, 80 and over , Carcinoma, Basal Cell/classification , Carcinoma, Basal Cell/pathology , Eyelid Neoplasms/classification , Eyelid Neoplasms/pathology , Female , Humans , Male , Middle Aged , Neoplasm Invasiveness , Prospective Studies , Sex Distribution , Treatment Outcome
2.
Acta Derm Venereol ; 76(6): 444-6, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8982407

ABSTRACT

The antimycotic activity of fluconazole against the filamentous form of Pityrosporum ovale was studied in vitro. P. ovale was grown on human stratum corneum in vitro with and without the addition of different concentrations of fluconazole. In control cultures hyphae were produced in 25% of the cells compared to only 4% after exposure to fluconazole 1 microgram/ml. In control cultures 16% of the fungal cells showed signs of necrosis, due to the normal turnover rate of the cells, compared to 65% of the fungal cells exposed to 1 microgram/ml of fluconazole. In the transmission electron microscope the typical thick-walled fungal cells with their characteristic budding were observed in control cultures. However, after exposure to 1 microgram/ml of fluconazole that P. ovale cells showed extensive signs of necrosis, with loss of internal organelles and disinterruption of the cell wall. The results obtained in this in vitro model mimic the in vivo situation in pityriasis versicolor. There is a parallel between the good results obtained in this system and the good clinical effect of fluconazole in Pityrosporum-related diseases.


Subject(s)
Antifungal Agents/pharmacology , Fluconazole/pharmacology , Malassezia/drug effects , Culture Techniques , Humans , Malassezia/ultrastructure
3.
Br J Cancer ; 67(1): 134-8, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8427773

ABSTRACT

In 82 patients with stage III malignant melanoma, the primary tumours were investigated by DNA flow cytometry. The tumours were classified as DNA diploid (n = 36), tetraploid (n = 11) and aneuploid (n = 35). By univariate analysis a significant correlation with post-recurrence survival was found for time to first metastasis, DNA-ploidy and S-phase fraction. By multivariate analysis, significant prognostic variables were found to be the time to first metastasis (P = 0.006), and ploidy (P = 0.011). Patients with diploid melanomas and a long recurrence-free interval had a median post-recurrence survival time of 45 months compared to 18 months in patients with DNA aneuploid tumours and an early recurrence. The S-phase could be estimated in 47 primary melanomas and was found to be a significant prognostic variable (P = 0.017). The median survival was 45 months for patients with melanomas with a S-phase fraction below 5%, and 19 months for melanomas with S-phase above 10%. The prognostic value of the S-phase remained significant even after adjustment for recurrence-free interval and DNA ploidy.


Subject(s)
DNA, Neoplasm/genetics , Melanoma/genetics , Ploidies , S Phase/physiology , Aged , Aneuploidy , Diploidy , Female , Humans , Male , Melanoma/pathology , Middle Aged , Neoplasm Staging , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...